CCFZ533X2201

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCFZ533X2201, covering 2018-12-21 to 2018-12-21. Get the full timeline:

Most recent: Clinical Trial Update: CCFZ533X2201 - PoC Study in de Novo Renal Transplantation [Phase 1, Phase 2]